Paraneoplastik Hepatik Sendromlar
Özet
Paraneoplastik hepatik sendromlar, primer tümör veya metastazlarının doğrudan etkisi olmaksızın, tümörden salgılanan hormon, peptit, sitokinler veya gelişen çapraz reaksiyonlar neticesinde karaciğerde meydana gelen fonksiyonel veya yapısal hasarlardır. Literatürde en sık karşılaşılan hepatik paraneoplastik sendromlar Kaybolan Safra Kanalı Sendromu (KSKS) ve Stauffer sendromudur. KSKS, intrahepatik safra kanallarının ilerleyici yıkımıyla kronik kolestaza yol açan nadir bir tablo olup, neoplastik etyolojide en sık Hodgkin lenfoma ile ilişkilendirilir. Sıklıkla sarılık ve kaşıntı ile prezente olan bu sendromda, altta yatan lenfomanın kemoterapi gibi yöntemlerle erken tedavisi karaciğer yetmezliğini önlemede hayati öneme sahiptir. Stauffer sendromu ise safra yolu tıkanıklığı ya da metastaz olmaksızın gelişen karaciğer disfonksiyonudur. Özellikle renal hücreli karsinom (RCC) başta olmak üzere genitoüriner tümörlerle ilişkili olup, patofizyolojisinde IL-6 yüksekliğinin rol oynadığı düşünülmektedir. En belirgin laboratuvar bulgusu alkalen fosfataz (ALP) yüksekliği olan bu sendromun temel tedavisi primer tümörün cerrahi rezeksiyonudur. Bunların dışında literatürde hepatik granülomlar, izole ALP yükseklikleri ve rejeneratif nodüler hiperplazi gibi tam tanımlanamayan atipik hepatik paraneoplastik olgular da bildirilmiştir. Sonuç olarak, açıklanamayan kolestaz ve karaciğer fonksiyon bozukluklarında bu sendromlar mutlaka akla gelmelidir.
Paraneoplastic hepatic syndromes represent distant organ dysfunctions that are not directly caused by the primary tumor or its metastases, but rather by tumor-secreted hormones, peptides, cytokines, or immune cross-reactions. The most frequently encountered hepatic paraneoplastic manifestations in the literature are Vanishing Bile Duct Syndrome (VBDS) and Stauffer syndrome. VBDS is a rare condition characterized by the progressive destruction of intrahepatic bile ducts, leading to chronic cholestasis, with Hodgkin lymphoma being the most common neoplastic cause. Presenting mostly with jaundice and pruritus, early diagnosis and treatment of the underlying malignancy via chemotherapy or bone marrow transplantation are critical to prevent fatal liver failure. Stauffer syndrome is characterized by liver dysfunction without biliary obstruction or direct hepatic metastasis, primarily associated with renal cell carcinoma (RCC). Elevated interleukin-6 (IL-6) is thought to play a central pathophysiological role, and alkaline phosphatase (ALP) elevation is the most prominent laboratory finding. Treating Stauffer syndrome relies on the surgical resection of the primary tumor, which typically resolves the hepatic abnormalities spontaneously. Other atypical and less defined paraneoplastic conditions include hepatic granulomas, isolated ALP elevations, and nodular regenerative hyperplasia. Recognizing these syndromes early is vital for favorable clinical outcomes.
Referanslar
Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 2010;85:838-854.doi.10.4065/mcp.2010.0099
Bhangoo MS, Cheng B, Botta GP, et al. Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome. Mol Clin Oncol 2018;8:609-612.doi.10.3892/mco.2018.1564
Bakhit M, McCarty TR, Park S, et al. Vanishing Bile Duct Syndrome in Hodgkin's Lymphoma: A Single Center Experience and Clinical Pearls. Journal Clin Gastroenterol 2016;50: 688. doi.10.1097/MCG.0000000000000548
Thapa B, Ramphul K. Paraneoplastic Syndromes. In: ed.^eds. StatPearls, ed. Treasure Island (FL): 2022.
Stolinsky DC. Paraneoplastic syndromes. West Journal Med 1980;132:189-208
Chavarriaga J, Fakih N, Catano J, et al. Stauffer syndrome, clinical implications and knowledge gaps, does size matter? Case report. BMC Urol 2020;20:105.doi.10.1186/s12894-020-00671-w
Anugwom C, Goetz G, Hassan M, et al. Vanishing Bile Duct Syndrome Preceding the Diagnosis of Hodgkin Lymphoma. ACG Case Rep Journal 2020;7: e00336. doi.10.14309/crj.0000000000000336
Wong KM, Chang CS, Wu CC, et al. Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review. Kaohsiung Journal Med Sci 2013;29:636-641.doi.10.1016/j.kjms.2013.05.002
Sedhom D, Herrmann A, D'Souza M, et al. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis. ACG Case Rep Journal 2018;5:e95.doi.10.14309/crj.2018.95
Bunchorntavakul C, Reddy KR. Hepatic Manifestations of Lymphoproliferative Disorders. Clin Liver Dis 2019;23:293-308.doi.10.1016/j.cld.2018.12.010
Vanishing Bile Duct Syndrome. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
Boldizsar S, Rottek J, Schneider T, et al. Hodgkin's lymphoma-related vanishing bile duct syndrome. Orv Hetil 2021;162:884-888.doi.10.1556/650.2021.32093
Yeh KE, Marcus PS, Fong TL. Paraneoplastic Cholestasis Associated With Ovarian Dysgerminoma. Obstet Gynecol 2015;126:431-434.doi.10.1097/AOG.0000000000000699
Hubscher SG, Lumley MA, Elias E. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology 1993;17:70-77
Rota Scalabrini D, Caravelli D, Carnevale Schianca F, et al. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature. BMC Res Notes 2014;7:529.doi.10.1186/1756-0500-7-529
Adams DH, Hubscher SG, Shaw J, et al. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989;2:1122-1125.doi.10.1016/s0140-6736(89)91489-x
Nakanuma Y, Tsuneyama K, Harada K. Pathology and pathogenesis of intrahepatic bile duct loss. Journal Hepatobiliary Pancreat Surg 2001;8:303-315.doi.10.1007/s005340170002
Zafar M, Farooq M, Butler-Manuel W, et al. Vanishing Bile Duct Syndrome Associated With Non-Hodgkin's Lymphoma and Hepatitis E Virus Infection. Cureus 2022;14:e21328.doi.10.7759/cureus.21328
Rossini MS, Lorand-Metze I, Oliveira GB, et al. Vanishing bile duct syndrome in Hodgkin's disease: case report. Sao Paulo Med Journal 2000;118:154-157.doi.10.1590/s1516-31802000000500008
Ballonoff A, Kavanagh B, Nash R, et al. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol 2008;47:962-970.doi.10.1080/02841860701644078
Ludwig J, Wiesner RH, LaRusso NF. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. Journal Hepatol 1988;7:193-199.doi.10.1016/s0168-8278(88)80482-3
Reau NS, Jensen DM. Vanishing bile duct syndrome. Clin Liver Dis 2008;12:203-217, x.doi.10.1016/j.cld.2007.11.007
Gemelli M, Carbone M, Abbate MI, et al. Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature. Immunotherapy 2022;14:175-181.doi.10.2217/imt-2021-0078
Gonzalez R, Parmar P, Hardee S, et al. Hodgkin Lymphoma-related Vanishing Bile Duct Syndrome Cholestasis Resolved After Chemotherapy. Journal Pediatr Hematol Oncol 2022;44:e728-e732.doi.10.1097/MPH.0000000000002223
Papakonstantinou I, Kosmidou M, Papathanasiou K, et al. Paraneoplastic Intrahepatic Cholestasis in Supradiaphragmatic Classical Hodgkin Lymphoma Successfully Treated With Brentuximab Vedotin: A Case Report and Review of the Literature. In Vivo 2021;35:1951-1957.doi.10.21873/invivo.12462
Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. Journal Hepatol 2001;35:134-146.doi.10.1016/s0168-8278(01)00092-7
Barta SK, Yahalom J, Shia J, et al. Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma. Clin Lymphoma Myeloma 2006;7:77-82.doi.10.3816/CLM.2006.n.044
Fong M, Boyle S, Gutta N. Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin's lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure. BMJ Case Rep 2019;12.doi.10.1136/bcr-2018-227676
Hallen K, Sangfelt P, Nilsson T, et al. Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma - pathological development and restitution. Acta Oncol 2014;53:1271-1275.doi.10.3109/0284186X.2014.897001
Aleem A, Al-Katari M, Alsaleh K, et al. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission. Saudi Journal Gastroenterol 2013;19:286-289.doi.10.4103/1319-3767.121037
Bakhit M, McCarty TR, Park S, et al. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review. World Journal Gastroenterol 2017;23:366-372.doi.10.3748/wjg.v23.i2.366
Palapattu GS, Kristo B, Rajfer J. Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. Rev Urol 2002;4:163-170
Sharma N, Darr U, Darr A, et al. Stauffer Syndrome: A Comprehensive Review of the Icteric Variant of the Syndrome. Cureus 2019;11:e6032.doi.10.7759/cureus.6032
Morla D, Alazemi S, Lichtstein D. Stauffer's syndrome variant with cholestatic jaundice: a case report. Journal Gen Intern Med 2006;21:C11-13.doi.10.1111/j.1525-1497.2006.00448.x
Sharma N, Darr U, Darr A, et al. Stauffer Syndrome: A Comprehensive Review of the Icteric Variant of the Syndrome. Cureus 2019;11:e6032.doi.10.7759/cureus.6032
Zarrabi K, Masic S, Schaefer C, et al. Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndrome. Urol Case Rep 2020;29:101077.doi.10.1016/j.eucr.2019.101077
Harris D, Saif MW. Stauffer's Syndrome in Pancreatic Cancer: First Case Report. Cureus 2017;9:e1230.doi.10.7759/cureus.1230
Romasovs A, Pukitis A, Mokricka V, et al. Stauffer's Syndrome in Patient with Metastatic Prostate Cancer. Case Rep Urol 2019;2019:9745301.doi.10.1155/2019/9745301
Tanous B, Alsaud A, Mahmoud KE, et al. A Rare Presentation of Stauffer's Syndrome Associated with Renal Cell Carcinoma. Case Rep Oncol 2020;13:742-746.doi.10.1159/000508039
Kranidiotis GP, Voidonikola PT, Dimopoulos MK, et al. Stauffer's syndrome as a prominent manifestation of renal cancer: a case report. Cases Journal 2009;2:49.doi.10.1186/1757-1626-2-49
Hinostroza-Yanahuaya J, Mon-Mon C, Ortega-Marcos O, et al. Stauffer syndrome and prostate carcinoma, two cases in chronic haemodialysis patients. Nefrologia 2013;33:749-750.doi.10.3265/Nefrologia.pre2013.May.10953
Mehta D, Chugh P, Chawla L, et al. Paraneoplastic Hepatopathy Associated with Gastrointestinal Carcinoid. ACG Case Rep Journal 2017;4:e117.doi.10.14309/crj.2017.117
Song S, Hartnett D, Tan S, et al. The Great Imposter: A Confusing Case of a Rare Renal Cell Carcinoma. R I Med Journal (2013) 2020;103:35-37
Dewana SK, Parmar KM, Sharma G, et al. Paraneoplastic hepatic dysfunction with jaundice in a case of primary renal synovial sarcoma: A very rare scenario. Urol Case Rep 2019;24:100841.doi.10.1016/j.eucr.2019.100841
Moreno-Palacios J, Wingartz-Plata H, Pardo-Belasteguigoitia P, et al. Stauffer syndrome in transitional cell carcinoma of the bladder. Arch Esp Urol 2011;64:911-913
Mazokopakis EE, Papadakis JA, Kofteridis DP. Unusual causes of intrahepatic cholestatic liver disease. World Journal Gastroenterol 2007;13:1879-1882.doi.10.3748/wjg.v13.i12.1879
Boxer RJ, Waisman J, Lieber MM, et al. Non-metastatic hepatic dysfunction associated with renal carcinoma. Journal Urol 1978;119:468-471.doi.10.1016/s0022-5347(17)57519-9
Blay JY, Rossi JF, Wijdenes J, et al. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int Journal Cancer 1997;72:424-430.doi.10.1002/(sici)1097-0215(19970729)72:3<424::aid-ijc9>3.0.co;2-r
Karakolios A, Kasapis C, Kallinikidis T, et al. Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma. Clin Gastroenterol Hepatol 2003;1:480-483. doi.10.1016/s1542-3565(03)00227-1
Denaro N, Garrone O, Occelli M, et al. Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review. Eur Journal Case Rep Intern Med 2021;8:002639.doi.10.12890/2021_002639
Casal Alvarez J, Treceno Garcia AA, Rodriguez Perez B. [Syndrome of Stauffer: A lethal stranger]. Aten Primaria 2022;54:102257. doi.10.1016/j.aprim.2021.102257
Kuronya Z, Kovacs E, Lahm E, et al. [Successful sunitinib treatment of a patient with Stauffer's syndrome]. Magy Onkol 2014;58:162-165
Fonseka CL, Kariyawasam A, Singhapura S, et al. Metastatic Renal Cell Carcinoma Presenting as Prolonged Pyrexia and Stauffer's Syndrome: Can a Routine Ultrasound Scan Fail to Detect a Renal Cell Carcinoma? Case Rep Radiol 2018;2018:4215041.doi.10.1155/2018/4215041
Kato D, Okwara C, Moreland C, et al. Hepatic Dysfunction as a Paraneoplastic Manifestation of Metastatic Prostate Adenocarcinoma. Journal Investig Med High Impact Case Rep 2014;2:2324709614539927. doi.10.1177/2324709614539927
Gokcen P, Gokcen K, Cakmak E, et al. Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature. Turk Journal Urol 2019;45:70-72.doi.10.5152/tud.2018.52059
Chagnac A, Gal R, Kimche D, et al. Liver Granulomas: A Possible Paraneoplastic Manifestation of Hypernephroma. American Journal of Gastroenterology (Springer Nature) 1985;80
Suzuki A, Takahashi T, Okuno Y, et al. Liver damage in patients with colony-stimulating factor-producing tumors. Am Journal Med 1993;94:125-132.doi.10.1016/0002-9343(93)90173-m
Henderson AR, Grace DM. Liver-originating isoenzymes of alkaline phosphatase in the serum: a paraneoplastic manifestation of a malignant schwannoma of the sciatic nerve. Journal Clin Pathol 1976;29:237-240.doi.10.1136/jcp.29.3.237
Hoshino T, Kumasaka K, Kawano K, et al. Abnormal alkaline phosphatase of hepatic type in cerebrospinal fluid of a patient with intracranial metastasis from lung cancer. Journal Clin Pathol 1993;46:1059-1061.doi.10.1136/jcp.46.11.1059
Bisagni G, Boni C, Fornaciari G, et al. Soft tissues sarcoma with acute paraneoplastic hepatic dysfunction: case report. Tumori 1996;82:499-501
Dourakis SP, Tzemanakis E, Deutsch M, et al. Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease. Eur Journal Gastroenterol Hepatol 1999;11:1055-1058.doi.10.1097/00042737-199909000-00019
Zaman A, Bramley PN, Wyatt J, et al. Hodgkin's disease presenting as liver abscesses. Gut 1991;32:959-962.doi.10.1136/gut.32.8.959
Dumas K, Wilbur M, Dillon J, et al. Paraneoplastic nodular regenerative hyperplasia of the liver associated with placental site trophoblastic tumor. Gynecol Oncol Rep 2019;29:16-19.doi.10.1016/j.gore.2019.05.003
